Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8453)
All Articles published online
|
Publishing Process of This Article
|
Apr 28, 2018 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Del Bello A, Congy-Jolivet N, Danjoux M, Muscari F, Lavayssière L, Esposito L, Hebral AL, Bellière J, Kamar N. High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation. World J Gastroenterol 2018; 24(16): 1795-1802 [PMID: 29713132 DOI: 10.3748/wjg.v24.i16.1795] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i16/1795.htm |
| Number | Citing Articles |
| 1 |
Mercè Brunet, Teun van Gelder, Anders Åsberg, Vincent Haufroid, Dennis A. Hesselink, Loralie Langman, Florian Lemaitre, Pierre Marquet, Christoph Seger, Maria Shipkova, Alexander Vinks, Pierre Wallemacq, Eberhard Wieland, Jean Baptiste Woillard, Markus J. Barten, Klemens Budde, Helena Colom, Maja-Theresa Dieterlen, Laure Elens, Kamisha L. Johnson-Davis, Paweł K. Kunicki, Iain MacPhee, Satohiro Masuda, Binu S. Mathew, Olga Millán, Tomoyuki Mizuno, Dirk-Jan A. R. Moes, Caroline Monchaud, Ofelia Noceti, Tomasz Pawinski, Nicolas Picard, Ron van Schaik, Claudia Sommerer, Nils Tore Vethe, Brenda de Winter, Uwe Christians, Stein Bergan. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report. Therapeutic Drug Monitoring 2019; 41(3): 261 doi: 10.1097/FTD.0000000000000640
|
| 2 |
Alexandra L. Degraeve, Vincent Haufroid, Axelle Loriot, Laurent Gatto, Vanessa Andries, Lars Vereecke, Laure Elens, Laure B. Bindels. Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1. Microbiome 2023; 11(1) doi: 10.1186/s40168-023-01578-y
|
| 3 |
S. Meganck, S. Raevens, K. Ferdinande, X. Verhelst, A. Hoorens, H. Degroote, A. Geerts, H. Van Vlierberghe. Recurrent rejections after liver transplantation for hepatocellular carcinoma with stem cell features in an adult patient. Acta Clinica Belgica 2024; 79(3): 234 doi: 10.1080/17843286.2024.2376304
|
| 4 |
Caner Süsal, Güclü Aykut, Christian Morath, Alexander Fichtner, Christian Unterrainer, Sabine Scherer, Thuong H. Tran, Arianeb Mehrabi, Martin Zeier, Burkhard Tönshoff. Relevance of donor‐specific antibody monitoring after kidney transplantation: Findings from the Collaborative Transplant Study and the Heidelberg Transplant Center. HLA 2019; 94(S2): 11 doi: 10.1111/tan.13665
|
| 5 |
Tawfik Khoury, Yaron Ilan. Introducing Patterns of Variability for Overcoming Compensatory Adaptation of the Immune System to Immunomodulatory Agents: A Novel Method for Improving Clinical Response to Anti-TNF Therapies. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02726
|
| 6 |
Huaijun Zhu, Min Wang, Xiaofu Xiong, Yao Du, Danying Li, Zhou Wang, Weihong Ge, Yizhun Zhu. Plasma metabolomic profiling reveals factors associated with dose-adjusted trough concentration of tacrolimus in liver transplant recipients. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1045843
|
| 7 |
Daryl U. Nnani, Alesa Campbell, Maria Ajaimy, Omar Saeed, Snehal R. Patel, Sana Ahmed, Jay A. Graham, Ulrich P. Jorde. Effect of glecaprevir/pibrentasvir on weight‐adjusted tacrolimus trough/dose ratios in heart and kidney transplant recipients. Transplant Infectious Disease 2021; 23(5) doi: 10.1111/tid.13716
|
| 8 |
Arnaud Del Bello, Clotilde Gaible, Nathalie Longlune, Anne-Laure Hebral, Laure Esposito, Peggy Gandia, Nassim Kamar. Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.602764
|
| 9 |
Amedeo De Nicolò, Michele Pinon, Alice Palermiti, Antonello Nonnato, Alessandra Manca, Jacopo Mula, Silvia Catalano, Francesco Tandoi, Renato Romagnoli, Antonio D’Avolio, Pier Luigi Calvo. Monitoring Tacrolimus Concentrations in Whole Blood and Peripheral Blood Mononuclear Cells: Inter- and Intra-Patient Variability in a Cohort of Pediatric Patients. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.750433
|
| 10 |
Hyunmin Ko, Hyo Kee Kim, Chris Chung, Ahram Han, Seung-Kee Min, Jongwon Ha, Sangil Min. Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-84868-5
|
| 11 |
M. Haripriyaa, K. Suthindhiran, M.A. Jayasri. Human and Animal Microbiome Engineering. 2025; : 179 doi: 10.1016/B978-0-443-22348-8.00010-6
|
| 12 |
Kayla B. Evans, Kristi J. Beermann, Hui-Jie Lee, Matt Harris, Courtney W. Frankel, Holly Berry, Hakim Azfar Ali. Impact of Tacrolimus Trough Variability on Acute Rejection Following Lung Transplantation. Transplantation Proceedings 2022; 54(8): 2270 doi: 10.1016/j.transproceed.2022.08.007
|
| 13 |
Maria Eduarda Soares, Gabriela Costa, Laura Guerra, Maria Clara Morais, Nayana Vaz, Liana Codes, Paulo Lisboa Bittencourt. Influence of Tacrolimus Intrapatient Variability on Allograft Rejection Frequency and Survival Following Liver Transplantation. Therapeutic Drug Monitoring 2024; 46(4): 456 doi: 10.1097/FTD.0000000000001192
|
| 14 |
Yaron Ilan. Second-Generation Digital Health Platforms: Placing the Patient at the Center and Focusing on Clinical Outcomes. Frontiers in Digital Health 2020; 2 doi: 10.3389/fdgth.2020.569178
|
| 15 |
Françoise Smets. Pediatric Liver Transplantation. 2021; : 157 doi: 10.1016/B978-0-323-63671-1.00018-5
|
| 16 |
Noa Hurvitz, Tama Dinur, Shoshana Revel-Vilk, Samuel Agus, Marc Berg, Ari Zimran, Yaron Ilan. A Feasibility Open-Labeled Clinical Trial Using a Second-Generation Artificial-Intelligence-Based Therapeutic Regimen in Patients with Gaucher Disease Treated with Enzyme Replacement Therapy. Journal of Clinical Medicine 2024; 13(11): 3325 doi: 10.3390/jcm13113325
|
| 17 |
Teun van Gelder. A new method to calculate intra‐patient variability in tacrolimus concentrations. British Journal of Clinical Pharmacology 2022; 88(6): 2581 doi: 10.1111/bcp.14865
|
| 18 |
Marina Serper, Alexander Burdzy, Douglas E Schaubel, Richard Mason, Arpita Banerjee, David S Goldberg, Eric F Martin, Shivan J Mehta, Louise B Russell, Amanda C Cheung, Daniela P Ladner, Julia Yoshino Benavente, Michael S Wolf. Patient randomised controlled trial of technology enabled strategies to promote treatment adherence in liver transplantation: rationale and design of the TEST trial. BMJ Open 2023; 13(9): e075172 doi: 10.1136/bmjopen-2023-075172
|
| 19 |
Mercè Brunet, Marçal Pastor-Anglada. Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics. Pharmaceutics 2022; 14(9): 1755 doi: 10.3390/pharmaceutics14091755
|
| 20 |
Ram Gelman, Marc Berg, Yaron Ilan. A Subject-Tailored Variability-Based Platform for Overcoming the Plateau Effect in Sports Training: A Narrative Review. International Journal of Environmental Research and Public Health 2022; 19(3): 1722 doi: 10.3390/ijerph19031722
|
| 21 |
SungHyo An, Sanghoon Lee, Jinsoo Rhu, Jong Man Kim, Gyu-Seong Choi, Jae-Won Joh. Safety and Efficacy of Conversion to Once-Daily Tacrolimus from Twice-Daily Tacrolimus in Pediatric Liver Transplant Recipients. Journal of Pediatric Surgery 2023; 58(10): 2054 doi: 10.1016/j.jpedsurg.2023.05.005
|
| 22 |
Anat Hershko-Moshe, Yaako’v Hasin, Anat Nevo-Shor, Ohad Etzion, Yaron Ilan, Soe Thiha Maung. Improving the Treatment Response of Patients with Irritable Bowel Syndrome: Implementing a Second-Generation Artificial Intelligence System for Overcoming Resistance. GastroHep 2022; 2022: 1 doi: 10.1155/2022/1192547
|
| 23 |
Yuval Ishay, Assaf Potruch, Asaf Schwartz, Marc Berg, Khurram Jamil, Samuel Agus, Yaron Ilan. A digital health platform for assisting the diagnosis and monitoring of COVID-19 progression: An adjuvant approach for augmenting the antiviral response and mitigating the immune-mediated target organ damage. Biomedicine & Pharmacotherapy 2021; 143: 112228 doi: 10.1016/j.biopha.2021.112228
|
| 24 |
Justa Friebus-Kardash, Ejona Nela, Birte Möhlendick, Andreas Kribben, Winfried Siffert, Falko Markus Heinemann, Ute Eisenberger. Development of De Novo Donor-specific HLA Antibodies and AMR in Renal Transplant Patients Depends on CYP3A5 Genotype. Transplantation 2022; 106(5): 1031 doi: 10.1097/TP.0000000000003871
|
| 25 |
Yaron Ilan, Zachary Spigelman. Establishing patient-tailored variability-based paradigms for anti-cancer therapy: Using the inherent trajectories which underlie cancer for overcoming drug resistance. Cancer Treatment and Research Communications 2020; 25: 100240 doi: 10.1016/j.ctarc.2020.100240
|
| 26 |
Eyal Shemesh. Using Medication Level Variability to Predict Posttransplant Risk. Liver Transplantation 2021; 27(6): 936 doi: 10.1002/lt.26012
|
| 27 |
Julien Vionnet, Christine Sempoux, Manuel Pascual, Alberto Sánchez-Fueyo, Jordi Colmenero. Donor-specific antibodies in liver transplantation. Gastroenterología y Hepatología (English Edition) 2020; 43(1): 34 doi: 10.1016/j.gastre.2019.09.004
|
| 28 |
Jordana Herblum, Niki Dacouris, Michael Huang, Jeffrey Zaltzman, G. V. Ramesh Prasad, Michelle Nash, Lucy Chen. Retrospective Analysis of Tacrolimus Intrapatient Variability as a Measure of Medication Adherence. Canadian Journal of Kidney Health and Disease 2021; 8 doi: 10.1177/20543581211021742
|
| 29 |
Hyun Jeong Kim, Juhan Lee, Jae Geun Lee, Dong Jin Joo, Myoung Soo Kim. Clinical association between tacrolimus intra-patient variability and liver transplantation outcomes in patients with and without hepatocellular carcinoma. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-20636-3
|
| 30 |
Nuttasith Larpparisuth, Tanapon Pongnatcha, Pera Panprom, Ratchawat Promraj, Nalinee Premasathian, Attapong Vongwiwatana. High Intrapatient Variability in Tacrolimus Exposure Calculated Over a Long Period Is Associated With De Novo Donor-Specific Antibody Development and/or Late Rejection in Thai Kidney Transplant Patients Receiving Concomitant CYP3A4/5 Inhibitors. Therapeutic Drug Monitoring 2021; 43(5): 624 doi: 10.1097/FTD.0000000000000850
|
| 31 |
Thomas Berg, Niklas F. Aehling, Tony Bruns, Martin-Walter Welker, Tobias Weismüller, Jonel Trebicka, Frank Tacke, Pavel Strnad, Martina Sterneck, Utz Settmacher, Daniel Seehofer, Eckart Schott, Andreas Anton Schnitzbauer, Hartmut H. Schmidt, Hans J. Schlitt, Johann Pratschke, Andreas Pascher, Ulf Neumann, Steffen Manekeller, Frank Lammert, Ingo Klein, Gabriele Kirchner, Markus Guba, Matthias Glanemann, Cornelius Engelmann, Ali E. Canbay, Felix Braun, Christoph P. Berg, Wolf O. Bechstein, Thomas Becker, Christian Trautwein. S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV). Zeitschrift für Gastroenterologie 2024; 62(09): 1397 doi: 10.1055/a-2255-7246
|
| 32 |
Dirk R.J. Kuypers. Intrapatient Variability of Tacrolimus Exposure in Solid Organ Transplantation: A Novel Marker for Clinical Outcome. Clinical Pharmacology & Therapeutics 2020; 107(2): 347 doi: 10.1002/cpt.1618
|
| 33 |
Assaf Potruch, Salim T. Khoury, Yaron Ilan. The role of chronobiology in drug-resistance epilepsy: The potential use of a variability and chronotherapy-based individualized platform for improving the response to anti-seizure drugs. Seizure 2020; 80: 201 doi: 10.1016/j.seizure.2020.06.032
|
| 34 |
Charat Thongprayoon, Panupong Hansrivijit, Karthik Kovvuru, Swetha R. Kanduri, Tarun Bathini, Aleksandra Pivovarova, Justin R. Smith, Wisit Cheungpasitporn. Impacts of High Intra- and Inter-Individual Variability in Tacrolimus Pharmacokinetics and Fast Tacrolimus Metabolism on Outcomes of Solid Organ Transplant Recipients. Journal of Clinical Medicine 2020; 9(7): 2193 doi: 10.3390/jcm9072193
|
| 35 |
Maria Clara Morais, Maria Eduarda Soares, Gabriela Costa, Laura Guerra, Nayana Vaz, Liana Codes, Paulo Lisboa Bittencourt. Impact of tacrolimus intra-patient variability in adverse outcomes after organ transplantation. World Journal of Transplantation 2023; 13(5): 254-263 doi: 10.5500/wjt.v13.i5.254
Abstract(471) |
Core Tip(506) |
Full Article(HTML)(1848)
|
Full Article with Cover (PDF)-694K(170)
|
Full Article (Word)-204K(35)
|
Audio-188K(0)
|
Peer-Review Report-329K(46)
|
Answering Reviewers-104K(75)
|
Full Article (PDF)-424K(151)
|
Full Article (XML)-165K(56)
|
Times Cited (0)
|
Total Visits (4444)
|
Open
|
| 36 |
Yaron Ilan. Next-Generation Personalized Medicine: Implementation of Variability Patterns for Overcoming Drug Resistance in Chronic Diseases. Journal of Personalized Medicine 2022; 12(8): 1303 doi: 10.3390/jpm12081303
|
| 37 |
Gwendal Coste, Florian Lemaitre. The Role of Intra-Patient Variability of Tacrolimus Drug Concentrations in Solid Organ Transplantation: A Focus on Liver, Heart, Lung and Pancreas. Pharmaceutics 2022; 14(2): 379 doi: 10.3390/pharmaceutics14020379
|
| 38 |
Caner Süsal, Bernd Döhler. Late intra-patient tacrolimus trough level variability as a major problem in kidney transplantation: A Collaborative Transplant Study Report. American Journal of Transplantation 2019; 19(10): 2805 doi: 10.1111/ajt.15346
|
| 39 |
Julien Vionnet, Christine Sempoux, Manuel Pascual, Alberto Sánchez-Fueyo, Jordi Colmenero. Donor-specific antibodies in liver transplantation. Gastroenterología y Hepatología 2020; 43(1): 34 doi: 10.1016/j.gastrohep.2019.09.010
|
| 40 |
Ewa Kwiatkowska, Kazimierz Ciechanowski, Leszek Domański, Violetta Dziedziejko, Jarosław Przybyciński, Andrzej Pawlik. Intrapatient Variability (IPV) and the Blood Concentration Normalized by the Dose (C/D Ratio) of Tacrolimus—Their Correlations and Effects on Long-Term Renal Allograft Function. Biomedicines 2022; 10(11): 2860 doi: 10.3390/biomedicines10112860
|
| 41 |
Samuel Walters, Stephanie Yerkovich, Peter M Hopkins, Trish Leisfield, Lesleigh Winks, Daniel C Chambers, Chandima Divithotawela. Erratic tacrolimus levels at 6 to 12 months post-lung transplant predicts poor outcomes. JHLT Open 2024; 3: 100043 doi: 10.1016/j.jhlto.2023.100043
|
| 42 |
Fang Chen, June-Kong Yong, Chuan Shen, Tao Zhou, Mingxuan Feng, Ping Wan, Yi Luo, Houwen Lin, Yongbing Qian, Qiang Xia. High intra-patient variability of tacrolimus within post-operative 1 month predicted worse 1-year outcomes in pediatric liver transplant recipients. European Journal of Clinical Pharmacology 2024; 80(7): 1017 doi: 10.1007/s00228-024-03663-z
|
| 43 |
Ariel Kenig, Yotam Kolben, Rabea Asleh, Offer Amir, Yaron Ilan. Improving Diuretic Response in Heart Failure by Implementing a Patient-Tailored Variability and Chronotherapy-Guided Algorithm. Frontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.695547
|
| 44 |
Kosuke Takano, Sayaka Kobayashi, Hidehiro Oshibuchi, Junko Tsutsui, Nano Mishima, Satoko Ito, Rumiko Kamba, Rie Akaho, Katsuji Nishimura. Association of the Stanford Integrated Psychosocial Assessment for Transplant and 1-Year Outcome of Living Kidney Transplantation in Japan. Journal of the Academy of Consultation-Liaison Psychiatry 2024; 65(1): 14 doi: 10.1016/j.jaclp.2023.09.003
|
| 45 |
Yamei Li, Lin Yan, Yi Li, Zhengli Wan, Yangjuan Bai, Xianding Wang, Shumeng Hu, Xiaojuan Wu, Cuili Yang, Jiwen Fan, Huan Xu, Lanlan Wang, Yunying Shi. Development and validation of routine clinical laboratory data derived marker-based nomograms for the prediction of 5-year graft survival in kidney transplant recipients. Aging 2021; 13(7): 9927 doi: 10.18632/aging.202748
|
| 46 |
Daniel N. Marco, María Queralt Salas, Gonzalo Gutiérrez-García, Inés Monge, Gisela Riu, Esther Carcelero, Joan Ramón Roma, Noemí Llobet, Jordi Arcarons, María Suárez-Lledó, Nuria Martínez, Alexandra Pedraza, Ariadna Domenech, Laura Rosiñol, Francesc Fernández-Avilés, Álvaro Urbano-Ispízua, Montserrat Rovira, Mercè Brunet, Carmen Martínez. Impact of Early Intrapatient Variability of Tacrolimus Concentrations on the Risk of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide. Pharmaceuticals 2022; 15(12): 1529 doi: 10.3390/ph15121529
|
| 47 |
Rongrong Wang, Weili Wang, Kuifen Ma, Xin Duan, Fangfang Wang, Mingzhu Huang, Wei Zhang, Tingbo Liang. Variation in Tacrolimus Trough Concentrations in Liver Transplant Patients Undergoing Endoscopic Retrograde Cholangiopancreatography: A Retrospective, Observational Study. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01252
|
| 48 |
Sasha Deutsch‐Link, Ethan M. Weinberg, Therese Bittermann, Mackenzie McDougal, Aniket Dhariwal, Lauren S. Jones, Robert M. Weinrieb, Arpita G. Banerjee, Senayish Addis, Marina Serper. The Stanford Integrated Psychosocial Assessment for Transplant Is Associated With Outcomes Before and After Liver Transplantation. Liver Transplantation 2021; 27(5): 652 doi: 10.1002/lt.25975
|
| 49 |
Steven C. Kim, David P. Foley. Donor-specific antibodies in liver transplantation: challenges in diagnosis and determining clinical impact. Current Opinion in Organ Transplantation 2020; 25(6): 549 doi: 10.1097/MOT.0000000000000825
|
| 50 |
Jérôme Dumortier, Camille Besch, Lucile Moga, Audrey Coilly, Filomena Conti, Christophe Corpechot, Arnaud Del Bello, François Faitot, Claire Francoz, Marie-Noëlle Hilleret, Pauline Houssel-Debry, Caroline Jezequel, Laurence Lavayssière, Martine Neau-Cransac, Domitille Erard-Poinsot, Victor de Lédinghen, Marc Bourlière, Christophe Bureau, Nathalie Ganne-Carrié. Non-invasive diagnosis and follow-up in liver transplantation. Clinics and Research in Hepatology and Gastroenterology 2022; 46(1): 101774 doi: 10.1016/j.clinre.2021.101774
|
| 51 |
Nobuhiro Fujiyama, Shigeru Satoh, Mitsuru Saito, Kazuyuki Numakura, Takamitsu Inoue, Ryohei Yamamoto, Takuro Saito, Taketoshi Nara, Sohei Kanda, Shintaro Narita, Hideaki Kagaya, Masatomo Miura, Tomonori Habuchi. Association of immunosuppressive agents and cytomegalovirus infection with de novo donor-specific antibody development within 1 year after renal transplantation. International Immunopharmacology 2019; 76: 105881 doi: 10.1016/j.intimp.2019.105881
|
| 52 |
Suwasin Udomkarnjananun, Marith I. Francke, Brenda C.M. De Winter, Midas B. Mulder, Carla C. Baan, Herold J. Metselaar, Caroline M. den Hoed, Dennis A. Hesselink. Therapeutic drug monitoring of immunosuppressive drugs in hepatology and gastroenterology. Best Practice & Research Clinical Gastroenterology 2021; : 101756 doi: 10.1016/j.bpg.2021.101756
|
| 53 |
Sanyam Santosh Falari, Nihar Mohapatra, Nilesh Sadashiv Patil, Bramhadatta Pattnaik, Mohit Varshney, Ashok Choudhury, Shiv K. Sarin, Viniyendra Pamecha. Incidence and predictors of alcohol relapse following living donor liver transplantation for alcohol related liver disease. Journal of Hepato-Biliary-Pancreatic Sciences 2023; 30(8): 1015 doi: 10.1002/jhbp.1325
|
| 54 |
Sherene Lattimore, Anastasia Chambers, Isabella Angeli-Pahim, Abhishek Shrestha, Benjamin O. Eke, Ariel Pomputius, Carma Bylund, Megan E. Gregory, Ali Zarrinpar. Impact of Intrapatient Immunosuppression Variability in Liver Transplantation Outcomes: A Systematic Review and Meta-analysis. Transplantation Direct 2024; 10(9): e1700 doi: 10.1097/TXD.0000000000001700
|
| 55 |
Taisa J. Kohut, Jose F. Barandiaran, Brendan J. Keating. Genomics and Liver Transplantation: Genomic Biomarkers for the Diagnosis of Acute Cellular Rejection. Liver Transplantation 2020; 26(10): 1337 doi: 10.1002/lt.25812
|
| 56 |
Marina Serper, Adwait Chafale, Alex Burdzy, Minjee Kim, Sumeet K. Asrani, Julia Yoshino Benavente, Richard Gershon, Peter P. Reese, Douglas E. Schaubel, Justin R. Boike, Maria C. Blanco, Michael S. Wolf. Cognitive function, self-management, and outcomes among liver transplant recipients: LivCog, a multicenter, prospective study. Hepatology Communications 2023; 7(10) doi: 10.1097/HC9.0000000000000259
|
| 57 |
Wei Song, Qianying Lao, Jinwei Hu, Danying Li, Yao Du, Huaijun Zhu. Lower tacrolimus time in therapeutic range is associated with inferior outcomes in adult liver transplant recipients. Basic & Clinical Pharmacology & Toxicology 2023; 132(1): 51 doi: 10.1111/bcpt.13803
|
| 58 |
Aleixandra Mendoza Rojas, Dennis A. Hesselink, Nicole M. van Besouw, Carla C. Baan, Teun van Gelder. Impact of low tacrolimus exposure and high tacrolimus intra-patient variability on the development of de novo anti-HLA donor-specific antibodies in kidney transplant recipients. Expert Review of Clinical Immunology 2019; 15(12): 1323 doi: 10.1080/1744666X.2020.1693263
|
| 59 |
Sasha Deutsch-Link, Robert M. Weinrieb, Lauren S. Jones, Steven F. Solga, Ethan M. Weinberg, Marina Serper. Prior Relapse, Ongoing Alcohol Consumption, and Failure to Engage in Treatment Predict Alcohol Relapse After Liver Transplantation. Digestive Diseases and Sciences 2020; 65(7): 2089 doi: 10.1007/s10620-019-05937-4
|
| 60 |
Abbie D. Leino, Manjunath P. Pai. Maintenance Immunosuppression in Solid Organ Transplantation: Integrating Novel Pharmacodynamic Biomarkers to Inform Calcineurin Inhibitor Dose Selection. Clinical Pharmacokinetics 2020; 59(11): 1317 doi: 10.1007/s40262-020-00923-w
|
| 61 |
Laura J. Wozniak, Robert S. Venick. Donor-specific antibodies following liver and intestinal transplantation: Clinical significance, pathogenesis and recommendations. International Reviews of Immunology 2019; 38(3): 106 doi: 10.1080/08830185.2019.1630404
|
| 62 |
Cristina Dopazo, Itxarone Bilbao, Sonia García, Concepción Gómez‐Gavara, Mireia Caralt, Isabel Campos‐Varela, Lluis Castells, Ernest Hidalgo, Francisco Moreso, Bruno Montoro, Ramón Charco. High intrapatient variability of tacrolimus exposure associated with poorer outcomes in liver transplantation. Clinical and Translational Science 2022; 15(6): 1544 doi: 10.1111/cts.13276
|
| 63 |
Lauren Schumacher, Abbie D. Leino, Jeong M. Park. Tacrolimus intrapatient variability in solid organ transplantation: A multiorgan perspective. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2021; 41(1): 103 doi: 10.1002/phar.2480
|
| 64 |
David Choi, Sarang Thaker, Patricia West-Thielke, Annesti Elmasri, Christine Chan. Evaluating the conversion to extended-release tacrolimus from immediate-release tacrolimus in liver transplant recipients. European Journal of Gastroenterology & Hepatology 2021; 33(8): 1124 doi: 10.1097/MEG.0000000000002172
|
| 65 |
Jessica Katharine Strong, Petra Gaylard, Heather Maher, Jean Botha. Acute Cellular Rejection in Paediatric Liver Transplants: Does a Living Donor Ameliorate the Risk of Rejection in Our Patients? A Retrospective Review at Wits Donald Gordon Medical Centre, South Africa. Wits Journal of Clinical Medicine 2019; 1(3) doi: 10.18772/26180197.2019.v1n3a1
|
| 66 |
Soo Bin Yoon, Jeong-Moo Lee, Chul-Woo Jung, Kyung-Suk Suh, Kwang-Woong Lee, Nam-Joon Yi, Suk Kyun Hong, YoungRok Choi, Su young Hong, Hyung-Chul Lee. Machine-learning model to predict the tacrolimus concentration and suggest optimal dose in liver transplantation recipients: a multicenter retrospective cohort study. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-71032-y
|